COMMUNIQUÉS West-GlobeNewswire

FDA Grants T2 Biosystems Breakthrough Device Designation for the T2Resistance™ Panel; Expected Availability through CE Mark in 2019
27/02/2019
New, expanded panel detects gram-negative and gram-positive resistance genes to help combat antimicrobial resistant bloodstream infections LEXINGTON, Mass., Feb. 27, 2019 (GLOBE NEWSWIRE) -- The FDA has granted T2 [...]
Teladoc Health Reports Fourth-Quarter and Full-Year 2018 Results
27/02/2019
Fourth-quarter revenue grows 59% to $122.7 million; Full-year 2018 revenue grows 79% to $417.9 million Fourth-quarter total visits up 86% to 861,000; 2018 total visits up 80% to 2.6 million Issues Initial 2019 Guidance [...]
NewLink Genetics Reports Fourth Quarter, Year-End 2018 Financial Results and Provides Update for Clinical Programs
27/02/2019
Management to Host Conference Call Today at 4:30 p.m. ET AMES, Iowa, Feb. 27, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today reported consolidated financial results for the fourth quarter and [...]
aTyr Pharma Presents Compelling Preclinical Data Highlighting Potential of ATYR1923 to Regulate Myeloid Cell Biology During Lung Inflammation
27/02/2019
Poster presentation at the Keystone Symposia 2019 Conference: Myeloid Cells (B7) SAN DIEGO, Feb. 27, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and [...]
GENFIT: PUBLICATION OF THE 2018 REGISTRATION DOCUMENT
27/02/2019
GENFIT: PUBLICATION OF THE 2018 REGISTRATION DOCUMENT Lille (France), Cambridge (Massachusetts, United States), February 27, 2019 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), a late-stage biopharmaceutical company [...]
GENFIT : MISE À DISPOSITION DU DOCUMENT DE RÉFÉRENCE 2018
27/02/2019
GENFIT : MISE À DISPOSITION DU DOCUMENT DE RÉFÉRENCE 2018 Lille (France), Cambridge (Massachusetts, États-Unis), le 27 février 2019 - GENFIT (Euronext : GNFT - ISIN : FR0004163111), Société biopharmaceutique de phase [...]
GENFIT : FILES REGISTRATION STATEMENT FOR PROPOSED INITIAL PUBLIC OFFERING IN THE UNITED STATES
27/02/2019
FOR IMMEDIATE RELEASE GENFIT FILES REGISTRATION STATEMENT FOR PROPOSED INITIAL PUBLIC OFFERING IN THE UNITED STATES Lille (France), Cambridge (Massachusetts, United States), February 27, 2019 GENFIT (Euronext: GNFT - [...]
GENFIT : ANNONCE LE DÉPÔT D'UN DOCUMENT D'ENREGISTREMENT EN VUE DE SON INTRODUCTION EN BOURSE ENVISAGÉE AUX ÉTATS-UNIS
27/02/2019
GENFIT ANNONCE LE DÉPÔT D'UN DOCUMENT D'ENREGISTREMENT EN VUE DE SON INTRODUCTION EN BOURSE ENVISAGÉE AUX ÉTATS-UNIS Lille (France), Cambridge (Massachusetts, États-Unis), le 27 février 2019 - GENFIT SA (Euronext : GNFT [...]
Aura Health Announces Closing of $1.9 Million on the First Tranche of Subscription Receipt Financing
27/02/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, Feb. 27, 2019 ( [...]
Teligent, Inc. to Present at The 8th Annual SVB Leerink Global Healthcare Conference Friday March 1, 2019
27/02/2019
BUENA, N.J., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at The 8 th Annual SVB Leerink Global Healthcare Conference [...]
Veloxis Pharmaceuticals Releases Annual Report for 2018
27/02/2019
Company Release no. 02/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 27 February 2019 Veloxis Pharmaceuticals Releases Annual Report for 2018 Veloxis Pharmaceuticals A/S (OMX: VELO) today releases its Annual [...]
RAMSAY GENERALE DE SANTE : Mise à disposition du rapport financier semestriel à fin décembre 2018
27/02/2019
Rapport financier semestriel au 31 décembre 2018 Ce document est disponible sur le site internet de RAMSAY GENERALE DE SANTE : http://www.ramsaygds.com A propos de Ramsay Générale de Santé : Après son OPA réussie sur le [...]
CORRECTING and REPLACING -- Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
27/02/2019
PHILADELPHIA and OXFORD, United Kingdom, Feb. 27, 2019 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Adaptimmune Therapeutics plc (Nasdaq:ADAP), please note that the third subheadline [...]
Loop Industries Announces $5.1 Million Registered Direct Offering
27/02/2019
BEDFORD, Mass. and MONTREAL, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Loop Industries, Inc. (Nasdaq:LOOP) (“Loop” or the “Company”), a leading sustainable plastics technology innovator, today announced that it has entered into [...]
Novozymes A/S’ annual shareholders’ meeting 2019
27/02/2019
Read the full announcement in PDF Attachment 2019_03_Novozymes_annual_shareholders_meeting_EN
RAMSAY GENERALE DE SANTE : half year results at the end of December 2018
27/02/2019
PRESS RELEASE Paris, 27 February 2019 Half-year results at the end of December 2018 Solid results were recorded in the first six months, and, moreover, the successful acquisition of the CAPIO Group opens up bright [...]
RAMSAY GENERALE DE SANTE : résultats semestriels à fin décembre 2018
27/02/2019
COMMUNIQUE DE PRESSE Paris, le 27 février 2019 Résultats semestriels à fin décembre 2018 Des résultats solides ont été enregistrés dans les six premiers mois et, par ailleurs, l'acquisition réussie du groupe CAPIO ouvre [...]
MEDIA ADVISORY: Logan Boulet’s family to announce inaugural Green Shirt Day
27/02/2019
LETHBRIDGE, Alberta, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Tony and Bernadine Boulet will announce details of the inaugural Green Shirt Day in memoriam of their son Logan Boulet and all the victims and survivors of the [...]
Nova Leap Health Corp. Announces Execution of Letter of Intent (LOI) to Acquire Home Care Services Business in Eastern Canada
27/02/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN HALIFAX, Nova Scotia, Feb. 27, 2019 (GLOBE NEWSWIRE) -- NOVA [...]

Pages